rs121913039
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM5PP3PP5_Very_Strong
The ENST00000252029.8(TYMP):c.622G>A(p.Val208Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000441 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V208G) has been classified as Pathogenic.
Frequency
Consequence
ENST00000252029.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYMP | NM_001953.5 | c.622G>A | p.Val208Met | missense_variant | 5/10 | ENST00000252029.8 | NP_001944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYMP | ENST00000252029.8 | c.622G>A | p.Val208Met | missense_variant | 5/10 | 1 | NM_001953.5 | ENSP00000252029 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000326 AC: 82AN: 251306Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135874
GnomAD4 exome AF: 0.000462 AC: 675AN: 1461658Hom.: 0 Cov.: 35 AF XY: 0.000457 AC XY: 332AN XY: 727130
GnomAD4 genome AF: 0.000243 AC: 37AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74332
ClinVar
Submissions by phenotype
Mitochondrial DNA depletion syndrome 1 Pathogenic:8
Pathogenic, criteria provided, single submitter | clinical testing | Department of Pathophysiology and Transplantation, University of Milan | Jul 04, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | GeneReviews | Jan 14, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 03, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 16, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2005 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 27, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 11, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 19, 2024 | Variant summary: TYMP c.622G>A (p.Val208Met) results in a conservative amino acid change located in the Glycosyl transferase, family 3 domain (IPR000312) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00033 in 251306 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in TYMP causing Mitochondrial DNA Depletion Syndrome 1 (MNGIE type) (0.00033 vs 0.0011), allowing no conclusion about variant significance. c.622G>A has been reported in the literature in individuals affected with Mitochondrial DNA Depletion Syndrome 1 (MNGIE type; Marti_2005, Ronchi_2020, Levy_2021). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 16178026, 32849836, 33300680). ClinVar contains an entry for this variant (Variation ID: 16663). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 15, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 208 of the TYMP protein (p.Val208Met). This variant is present in population databases (rs121913039, gnomAD 0.06%). This missense change has been observed in individual(s) with mitochondrial disease and/or mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) (PMID: 16178026, 32849836, 33300680). ClinVar contains an entry for this variant (Variation ID: 16663). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TYMP protein function. Studies have shown that this missense change alters TYMP gene expression (PMID: 32849836). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 29, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16178026, 19853446, 19748572, 21412940, 30487145, 32384880, 34426522, 33300680, 32849836) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at